Sarah K Holt1, Claudia A Salinas, Janet L Stanford. 1. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA. skholt@fhcrc.org
Abstract
PURPOSE: While the weight of evidence shows no association overall between vasectomy and prostate cancer, there has been some suggestion that an association may exist in subgroups, such as men who have a family history of prostate cancer, men who undergo vasectomy at a younger age or when several decades have passed since the procedure. Studies of risk with long latency periods have been hampered by small sample sizes in subgroups since vasectomy only became widely used in the 1960s and generally prostate cancer has a long latency period. MATERIALS AND METHODS: We analyzed data from a recent population based case-control study that was designed specifically to address this issue of risk in subgroups. Interviews were completed with 1,001 men diagnosed with prostate cancer from January 1, 2002 through December 31, 2005 in the Seattle-Puget Sound region and in 942 matched control men. Subjects were black and white men between the ages of 35 and 74 years. Data were analyzed using unconditional logistic regression to calculate the OR as an estimate of the relative risk of prostate cancer associated with various vasectomy parameters. RESULTS: The prevalence of vasectomy was similar in cases and controls (36.2% and 36.1%, respectively, adjusted OR 1.0, 95% CI 0.8-1.2). There were also no associations between prostate cancer and age at vasectomy, years elapsed since vasectomy or calendar year of vasectomy. CONCLUSIONS: These findings indicate that there is no association between vasectomy and the risk of prostate cancer.
PURPOSE: While the weight of evidence shows no association overall between vasectomy and prostate cancer, there has been some suggestion that an association may exist in subgroups, such as men who have a family history of prostate cancer, men who undergo vasectomy at a younger age or when several decades have passed since the procedure. Studies of risk with long latency periods have been hampered by small sample sizes in subgroups since vasectomy only became widely used in the 1960s and generally prostate cancer has a long latency period. MATERIALS AND METHODS: We analyzed data from a recent population based case-control study that was designed specifically to address this issue of risk in subgroups. Interviews were completed with 1,001 men diagnosed with prostate cancer from January 1, 2002 through December 31, 2005 in the Seattle-Puget Sound region and in 942 matched control men. Subjects were black and white men between the ages of 35 and 74 years. Data were analyzed using unconditional logistic regression to calculate the OR as an estimate of the relative risk of prostate cancer associated with various vasectomy parameters. RESULTS: The prevalence of vasectomy was similar in cases and controls (36.2% and 36.1%, respectively, adjusted OR 1.0, 95% CI 0.8-1.2). There were also no associations between prostate cancer and age at vasectomy, years elapsed since vasectomy or calendar year of vasectomy. CONCLUSIONS: These findings indicate that there is no association between vasectomy and the risk of prostate cancer.
Authors: K Zhu; J L Stanford; J R Daling; B McKnight; A Stergachis; M K Brawer; N S Weiss Journal: Am J Epidemiol Date: 1996-10-15 Impact factor: 4.897
Authors: Bimal Bhindi; Christopher J D Wallis; Madhur Nayan; Ann M Farrell; Landon W Trost; Robert J Hamilton; Girish S Kulkarni; Antonio Finelli; Neil E Fleshner; Stephen A Boorjian; R Jeffrey Karnes Journal: JAMA Intern Med Date: 2017-09-01 Impact factor: 21.873
Authors: Mohummad Minhaj Siddiqui; Kathryn M Wilson; Mara M Epstein; Jennifer R Rider; Neil E Martin; Meir J Stampfer; Edward L Giovannucci; Lorelei A Mucci Journal: J Clin Oncol Date: 2014-09-20 Impact factor: 44.544
Authors: Madhur Nayan; Robert J Hamilton; Erin M Macdonald; Qing Li; Muhammad M Mamdani; Craig C Earle; Girish S Kulkarni; Keith A Jarvi; David N Juurlink Journal: BMJ Date: 2016-11-03